a

3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.

+(91)-(22)-42643060

3scorp.india@gmail.com
Andheri East, Mumbai - 400099, India.

DISCLAIMER

All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00

+(91)-(22)-42643060

3scorp.india@gmail.com

Andheri East

Mumbai – 400099, India.

Mabthera 500 mg vial

Description

What is it?

MabThera is a concentrate that is made up into a solution for infusion (drip into a vein). It contains the active substance rituximab. It is manufactured by Roche. In India. it has been renamed to Ristova

What is it used for?

MabThera is used in adults to treat non-Hodgkin’s lymphoma (a cancer of the lymph tissue), chronic lymphocytic leukaemia (CLL, a cancer of the B-lymphocytes, a type of white blood cell) and rheumatoid arthritis (a disease that causes inflammation of the joints).
In non-Hodgkin’s lymphoma, MabThera is used to treat two types of the disease, both of which affect B-lymphocytes:

In follicular lymphoma, MabThera is used in combination with chemotherapy (medicines to treat cancer) in patients with advanced disease who have not been treated before. It can also be used as maintenance treatment in patients whose follicular lymphoma has responded to initial chemotherapy. It is also used on its own in patients with advanced disease who are resistant to chemotherapy or who have failed two or more chemotherapy treatments;

In patients with diffuse large B-cell lymphoma, MabThera is used in combination with a specific type of chemotherapy called ‘CHOP’ (cyclophosphamide, doxorubicin, vincristine and prednisolone).

In CLL, MabThera is used in combination with chemotherapy in patients who have not been treated before and in patients whose disease has come back after previous treatment.

In rheumatoid arthritis, MabThera is used in adults with severe disease in combination with methotrexate (a medicine that acts on the immune system). It is used in patients who cannot take or have not responded adequately to other treatments for rheumatoid arthritis, including a tumour necrosis factor (TNF) inhibitor.

Additional Information

Side Effects

Pack Size